Plotkin’s Vaccines

From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin's Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.

SECTION IGeneral Aspects of Vaccination1 A Short History of Vaccination2 Vaccine Immunology3 Non-specific Effects of Vaccines4 Correlates of Protection5 The Vaccine Industry6 Vaccine Manufacturing7 Evolution of Adjuvants Across the Centuries8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States9 Passive ImmunizationSECTION IILicenced Vaccines and Vaccines in Development10 General Immunization Practices11 Human Adenovirus Vaccines12 Anthrax Vaccines13 Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)14 Cancer Vaccines15 Cholera Vaccines16 Combination Vaccines17 Coronavirus Vaccines18 Cytomegalovirus Vaccines19 Dengue Vaccines20 Vaccines Against Diarrhea Caused by Noncholera Bacteria21 Diphtheria Toxoid22 Ebola Vaccines23 Nonpolio Enteroviruses24 Epstein-Barr Virus Vaccines25 Haemophilus Influenzae Type b Vaccines26 Hepatitis A Vaccines27 Hepatitis B Vaccines28 Hepatitis C Vaccines29 Hepatitis E Vaccines30 Herpes Simplex Virus Vaccines31 Human Immunodeficiency Virus Vaccines32 Human Papillomavirus Vaccines33 Inactivated and Recombinant Influenza Vaccines34 Influenza Vaccine-Live35 Japanese Encephalitis Vaccines36 Lyme Disease Vaccines-the Journey Continues37 Malaria Vaccines38 Measles Vaccines39 Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines40 Meningococcal Vaccines Directed at Capsular Group B41 Mumps Vaccines42 Noninfectious Disease Vaccines43 Norovirus44 Parasitic Disease Vaccines45 Pertussis Vaccines46 Plague Vaccines47 Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines48 Pneumococcal Polysaccharide Vaccines49 Poliovirus Vaccine-Inactivated50 Poliovirus Vaccine-Live51 Lyssaviruses and Rabies Vaccines52 Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies53 Rotavirus Vaccines54 Rubella Vaccines55 Smallpox and Vaccinia56 Staphylococcus aureus Vaccines57 Streptococcus Group A Vaccines58 Streptococcus Group B Vaccines59 Tetanus Toxoid60 Tickborne Encephalitis Vaccines61 Tuberculosis Vaccines62 Typhoid Fever Vaccines63 Varicella Vaccines64 Yellow Fever Vaccine65 Zika Virus Vaccines66 Zoster VaccinesSECTION IIINew Technologies67 Technologies for Making New Vaccines68 Genetic-Based Vaccine Vectors69 Technologies to Improve ImmunizationSECTION IVVaccination of Special Groups70 Vaccination of Immunocompromised Hosts71 Vaccines for International Travel72 Vaccines for Healthcare Personnel73 Vaccination of Pregnant WomenSECTION VPublic Health and Regulatory Issues74 Immunization in the United States75 Immunization in Europe76 Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region77 Immunization in Low- and Middle-Income Countries78 Community Protection79 Economic Analyses of Vaccine Policies80 Regulation and Testing of Vaccines in the US81 Regulation of Vaccines in Europe82 Regulation of Vaccines in Low- and Middle-Income Countries83 Vaccine Safety84 Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake85 Legal Issues86 EthicsONLINE ONLY87 Vaccines to Prevent MpoxAPPENDIXWebsites and Applications for Mobile Devices With Information About ImmunizationIndex